188 related articles for article (PubMed ID: 22054334)
21. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
[TBL] [Abstract][Full Text] [Related]
22. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
23. Individualising the risks of statins in men and women in England and Wales: population-based cohort study.
Hippisley-Cox J; Coupland C
Heart; 2010 Jun; 96(12):939-47. PubMed ID: 20489220
[TBL] [Abstract][Full Text] [Related]
24. Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2021 May; 71(706):e364-e371. PubMed ID: 33875417
[TBL] [Abstract][Full Text] [Related]
25. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score.
Hippisley-Cox J; Coupland C
BMJ Open; 2013 Aug; 3(8):e003482. PubMed ID: 23959760
[TBL] [Abstract][Full Text] [Related]
26. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores.
Hippisley-Cox J; Coupland C
BMJ; 2014 Jul; 349():g4606. PubMed ID: 25069704
[TBL] [Abstract][Full Text] [Related]
27. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
28. Early diagnosis of oesophageal cancer improves outcomes.
Hopper AD; Campbell JA
Practitioner; 2016 Mar; 260(1791):23-8, 3. PubMed ID: 27214976
[TBL] [Abstract][Full Text] [Related]
29. Comparison of oesophageal and gastric cancer in the evaluation of urgent endoscopy referral criteria.
Kumar L; Kholmurodova F; Bull J; Bright T; Watson DI; Shenfine J
ANZ J Surg; 2021 Jul; 91(7-8):1515-1520. PubMed ID: 34124837
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2015 Nov; 351():h5441. PubMed ID: 26560308
[TBL] [Abstract][Full Text] [Related]
31. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
Hippisley-Cox J; Coupland C; Robson J; Brindle P
BMJ; 2010 Dec; 341():c6624. PubMed ID: 21148212
[TBL] [Abstract][Full Text] [Related]
32. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
[TBL] [Abstract][Full Text] [Related]
33. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
34. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.
Hippisley-Cox J; Coupland C
BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929
[TBL] [Abstract][Full Text] [Related]
35. The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ Open; 2014 Aug; 4(8):e005809. PubMed ID: 25168040
[TBL] [Abstract][Full Text] [Related]
36. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.
Smithers BM; Fahey PP; Corish T; Gotley DC; Falk GL; Smith GS; Kiroff GK; Clouston AD; Watson DI; Whiteman DC
Med J Aust; 2010 Nov; 193(10):572-7. PubMed ID: 21077812
[TBL] [Abstract][Full Text] [Related]
37. Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data.
Stavrou EP; Ward R; Pearson SA
BMC Health Serv Res; 2012 Nov; 12():384. PubMed ID: 23136982
[TBL] [Abstract][Full Text] [Related]
38. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
39. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
[TBL] [Abstract][Full Text] [Related]
40. Gastro-oesophageal cancer: facts, myths and surgical folk lore.
Park KG
J R Coll Surg Edinb; 2002 Dec; 47(6):716-30. PubMed ID: 12510964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
